Key efficacy and safety of apremilast in patients with mild to moderate plaque psoriasis in the phase 3 ADVANCE trial Meeting Abstract

publication date

  • September 1, 2021

webpage

published in

start page

  • AB83

end page

  • AB83

volume

  • 85

issue

  • 3